Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,112 INR | +1.00% | -3.11% | +6.51% |
May. 16 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 | |
May. 16 | Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4 | MT |
Sales 2024 | 103B 1.24B | Sales 2025 * | 116B 1.39B | Capitalization | 838B 10.06B |
---|---|---|---|---|---|
Net income 2024 | 19.13B 230M | Net income 2025 * | 22.22B 267M | EV / Sales 2024 | 8.92 x |
Net cash position 2024 * | 25.25B 303M | Net cash position 2025 * | 52.14B 626M | EV / Sales 2025 * | 6.76 x |
P/E ratio 2024 |
48.3
x | P/E ratio 2025 * |
37.7
x | Employees | 18,468 |
Yield 2024 * |
0.33% | Yield 2025 * |
0.27% | Free-Float | 19.92% |
Latest transcript on Mankind Pharma Limited
1 day | +1.00% | ||
1 week | -3.11% | ||
Current month | -10.69% | ||
1 month | -9.66% | ||
3 months | -4.94% | ||
6 months | +4.91% | ||
Current year | +6.51% |
Managers | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 07-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 16-06-16 |
Pradeep Chugh
CMP | Compliance Officer | - | 16-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 22-07-31 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 22-07-31 |
Surendra Lunia
BRD | Director/Board Member | 61 | 15-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2,091 | -0.09% | 1,545,240 |
24-05-16 | 2,093 | -4.48% | 3,462,277 |
24-05-15 | 2,191 | -2.58% | 849,117 |
24-05-14 | 2,249 | +3.18% | 402,102 |
24-05-13 | 2,180 | -2.56% | 323,561 |
Delayed Quote NSE India S.E., May 18, 2024 at 03:15 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.51% | 10.05B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- MANKIND Stock